Northern Trust’s Twist Bioscience TWST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $60.9M | Buy |
591,688
+63,722
| +12% | +$4.15M | 0.01% | 1081 |
|
|
2026
Q1 | $25.1M | Buy |
527,966
+23,128
| +5% | +$1.04M | ﹤0.01% | 1531 |
|
|
2025
Q4 | $16M | Sell |
504,838
-20,204
| -4% | -$630K | ﹤0.01% | 1814 |
|
|
2025
Q3 | $14.8M | Sell |
525,042
-4,071
| -0.8% | -$123K | ﹤0.01% | 1886 |
|
|
2025
Q2 | $19.5M | Sell |
529,113
-87,751
| -14% | -$3.03M | ﹤0.01% | 1667 |
|
|
2025
Q1 | $24.2M | Sell |
616,864
-10,785
| -2% | -$486K | ﹤0.01% | 1515 |
|
|
2024
Q4 | $29.2M | Buy |
627,649
+51,926
| +9% | +$2.35M | ﹤0.01% | 1462 |
|
|
2024
Q3 | $26M | Buy |
575,723
+17,037
| +3% | +$811K | ﹤0.01% | 1461 |
|
|
2024
Q2 | $27.5M | Sell |
558,686
-14,567
| -3% | -$594K | ﹤0.01% | 1357 |
|
|
2024
Q1 | $19.7M | Sell |
573,253
-12,567
| -2% | -$454K | ﹤0.01% | 1606 |
|
|
2023
Q4 | $21.6M | Buy |
585,820
+31,564
| +6% | +$730K | ﹤0.01% | 1563 |
|
|
2023
Q3 | $11.2M | Buy |
554,256
+5,472
| +1% | +$120K | ﹤0.01% | 1916 |
|
|
2023
Q2 | $11.2M | Buy |
548,784
+27,780
| +5% | +$416K | ﹤0.01% | 1977 |
|
|
2023
Q1 | $7.86M | Buy |
521,004
+9,968
| +2% | +$220K | ﹤0.01% | 2182 |
|
|
2022
Q4 | $12.2M | Sell |
511,036
-2,585
| -0.5% | -$75K | ﹤0.01% | 1870 |
|
|
2022
Q3 | $18.1M | Sell |
513,621
-4,743
| -0.9% | -$201K | ﹤0.01% | 1559 |
|
|
2022
Q2 | $18.1M | Buy |
518,364
+5,462
| +1% | +$193K | ﹤0.01% | 1600 |
|
|
2022
Q1 | $25.3M | Buy |
512,902
+45,866
| +10% | +$2.54M | ﹤0.01% | 1511 |
|
|
2021
Q4 | $36.1M | Sell |
467,036
-8,019
| -2% | -$823K | 0.01% | 1349 |
|
|
2021
Q3 | $50.8M | Sell |
475,055
-30,062
| -6% | -$3.44M | 0.01% | 1062 |
|
|
2021
Q2 | $67.3M | Sell |
505,117
-10,499
| -2% | -$1.22M | 0.01% | 902 |
|
|
2021
Q1 | $63.9M | Buy |
515,616
+85,750
| +20% | +$13M | 0.01% | 930 |
|
|
2020
Q4 | $60.7M | Sell |
429,866
-6,465
| -1% | -$717K | 0.01% | 927 |
|
|
2020
Q3 | $33.1M | Buy |
436,331
+25,441
| +6% | +$1.58M | 0.01% | 1221 |
|
|
2020
Q2 | $18.6M | Buy |
410,890
+70,479
| +21% | +$2.53M | ﹤0.01% | 1682 |
|
|
2020
Q1 | $10.4M | Buy |
340,411
+55,019
| +19% | +$1.48M | ﹤0.01% | 1849 |
|
|
2019
Q4 | $5.99M | Buy |
285,392
+1,451
| +0.5% | +$34K | ﹤0.01% | 2482 |
|
|
2019
Q3 | $6.78M | Buy |
283,941
+154,071
| +119% | +$4.48M | ﹤0.01% | 2378 |
|
|
2019
Q2 | $3.77M | Buy |
129,870
+55,285
| +74% | +$1.46M | ﹤0.01% | 2709 |
|
|
2019
Q1 | $1.73M | Buy |
74,585
+5,049
| +7% | +$114K | ﹤0.01% | 3165 |
|
|
2018
Q4 | $1.6M | Buy |
+69,536
| New | +$1.54M | ﹤0.01% | 3164 |
|
Other funds holding TWST
AIM
EIG
Northern Trust's TWST Position: Q2 2026 in Review
Northern Trust increased its Twist Bioscience (TWST) stake by 12% in Q2 2026, buying an estimated $4.15M and bringing the position to 591,688 shares worth $60.9M. The position accounts for 0.01% of the portfolio, ranked #1081.
Northern Trust first reported a position in TWST in Q4 2018 and has held it in 31 quarters since. The position peaked at $67.3M in Q2 2021. 338 funds tracked by Wall St. Rank hold TWST as of Q2 2026.
- Northern Trust held 591,688 shares of Twist Bioscience worth $60.9M as of Q2 2026.
- Northern Trust bought 63,722 Twist Bioscience shares in Q2 2026, an estimated $4.15M.
- Twist Bioscience made up 0.01% of Northern Trust's portfolio in Q2 2026, its #1081 holding.
- Northern Trust first reported a position in Twist Bioscience in Q4 2018 and has held it in 31 quarters since.
- Northern Trust's Twist Bioscience position peaked at $67.3M in Q2 2021.
- 338 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.
Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.